How to improve post genomic knowledge discovery using imputation by Sehgal, Shoaib M. et al.
Open Research Online
The Open University’s repository of research publications
and other research outputs
How to improve post genomic knowledge discovery
using imputation
Journal Item
How to cite:
Sehgal, Shoaib M.; Gondal, Iqbal; Dooley, Laurence S. and Coppel, Ross (2009). How to improve post genomic
knowledge discovery using imputation. EURASIP Journal on Bioinformatics and Systems Biology, 2009(717136) pp.
1–14.
For guidance on citations see FAQs.
c© [not recorded]
Version: [not recorded]
Link(s) to article on publisher’s website:
http://dx.doi.org/doi:10.1155/2009/717136
http://www.hindawi.com/GetArticle.aspx?doi=10.1155/2009/717136
Copyright and Moral Rights for the articles on this site are retained by the individual authors and/or other copyright
owners. For more information on Open Research Online’s data policy on reuse of materials please consult the policies
page.
oro.open.ac.uk
1 
How to Improve Post Genomic Knowledge Discovery 
using Imputation 
Muhammad Shoaib B. Sehgal1,4, Iqbal Gondal2,4, Laurence S. Dooley5  and  Ross 
Coppel3,4 
1ARC Centre of Excellence in Bioinformatics at IMB, University of Queensland, St 
Lucia, QLD 4067, Australia,  2Faculty of Information Technology, Australia, 
3Department of Microbiology, Monash University, Australia, 5Faculty of 
Mathematics, Computing and Technology, The Open University, United Kingdom, 
4Victorian Bioinformatics Consortium 
{shoaib.sehgal@imb.uq.edu.au, Iqbal.Gondal@infotech.monash.edu.au, 
L.S.Dooley@open.ac.uk, ross.coppel@med.monash.edu.au} 
 
Abstract: While microarrays make it feasible to rapidly investigate many complex 
biological problems, their multi-step fabrication has the proclivity for error at 
every stage. The standard tactic has been to either ignore or regard erroneous gene 
readings as missing values, though this assumption can exert a major influence 
upon post genomic knowledge discovery methods like gene selection and Gene 
Regulatory Network (GRN) reconstruction. This has been the catalyst for a raft of 
new flexible imputation algorithms including, Local Least Square Impute and the 
recent Heuristic Collateral Missing Value Imputation, which exploit the biological 
transactional behaviour of functionally correlated genes to afford accurate missing 
value estimation. This paper examines the influence of missing value imputation 
techniques upon post genomic knowledge inference methods with results for 
various algorithms consistently corroborating that instead of ignoring missing 
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values, recycling microarray data by flexible and robust imputation can provide 
substantial performance benefits for subsequent down-stream procedures.   
1. Introduction 
The study of genes and their transactional relationship with other genes can be modelled 
using machine learning algorithms in a diverse range of applications from disease 
analysis1 and drug progression for target diseases2 through to evolutionary study3 and 
comparative genomics4, all of which are characterised by using microarray gene 
expression data. The statistical analysis of microarray datasets depends highly upon the 
accuracy of the gene expression methods. Microarray production is a complex process 
whereby samples are prepared for differential expression in a series of stages involving 
the laying of specimens on the slides by a robotic arm, imaging of the slides and finally 
determining the numerical gene expression values. Each step inevitably exhibits a 
propensity for error5, a corollary to this is the inherent erroneous gene expression values 
for certain genes, which are popularly referred to as missing values. While microarray 
technology is continually being refined, there is an enormous amount of public domain 
gene expression data available that frequently contains at least 5% erroneous spots. 
Indeed, in many datasets at least 60% of genes have either one or more missing values6, 
which can seriously impact on subsequent data analysis involving for example, 
significant gene selection, Gene Regulatory Network (GRN) reconstruction and 
clustering algorithms7,8.  
The simplest ways to address this problem are to either repeat the experiment, though 
this is often not feasible for economic reasons, or ignore those samples containing 
missing values, but again this is not recommended because of the limited number of 
available samples. Alternative strategies include row average/median imputation 
(substitution by the corresponding row average/median value) and the ubiquitous 
ZeroImpute where missing values are replaced by zero. Both approaches are high-
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variance, with neither exploiting the underlying data correlations which can lead to 
higher estimation errors9. The prevailing wisdom is to accurately estimate missing 
values by exploiting the latent correlation structure of the microarray data,8,10 as 
manifest by the development of numerous microarray imputation techniques including 
Collateral Missing Value Estimation (CMVE)11, Singular Value Decomposition Impute 
(SVDImpute)9, K-Nearest Neighbour (KNN)9, Least Square Impute (LSImpute)10, 
Local LSImpute (LLSImpute)8, Bayesian Principal Component Analysis (BPCA)12, a set 
theoretic framework based on Projection onto Convex Sets Imputation method (POCS 
Impute)13 and most recently, Heuristic Collateral Missing Value Imputation 
(HCMVI)14. In addition other methods which use contextual information include Gene 
Ontology based Imputation (GOImpute)15 and meta data based imputation technique 16. 
This paper will investigate the gene expression correlation assumption by empirically 
analysing different post-genomic knowledge discovery methods including gene 
selection and GRN reconstruction techniques in the presence of missing values, 
specifically for the breast and ovarian cancer datasets of Hedenfalk et al17 and Amir et 
al18 respectively. The rationale for choosing these two datasets is that generally 
cancerous data 19 lacks molecular homogeneity in tumour tissues which makes missing 
value estimation far more challenging. Additionally, breast cancer is the second leading 
cause of cancer death in women today (following lung cancer), with 1 in 11 Australian 
women being diagnosed with the disease before the age of 75 and the number of breast 
cancer patients increasing everyday, as diagnosis methods improve20. Ovarian cancer is 
the fourth most common cause of cancer-related deaths in American women of all ages, 
as well as being the most prevalent cause of death from gynaecologic malignancies in 
the United States21. 
Figure 1 displays a generic post genomic knowledge inference framework, with the 
DNA sample being firstly converted to expression values prior to any knowledge 
inference being undertaken. As highlighted earlier, this phase (STEP 1 in Figure 1) can 
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introduce several erroneous (missing) values that can significantly impact upon any 
subsequent analysis. Unfortunately, while there have been many propitious imputation 
algorithmic contributions (STEP 2), there is still the pervading fallacy that either new 
data analysis methods will successfully manage missing values or more seriously, that 
missing values in fact do not impact appreciably upon downstream analysis22. 
Interestingly, even though there have been some attempts to test the impact of 
imputation on clustering methods23,24, no comprehensive single study has been 
undertaken to date to analyse the impact missing values can have on different post 
genomic knowledge discovery methods like gene selection, class prediction, clustering 
of functionally related genes and GRN reconstruction (STEP 4). This paper cogently 
argues that imputation is both an integral and indeed mandatory pre-processing step 
(STEP 2) prior to applying any knowledge discovery method (STEP 4). This judgement 
is justified by analysing various results which consistently reveal improved estimation 
accuracy when missing values are approximated by more flexible approaches such as, 
HCMVI and LLSImpute (STEP 3) because of their innate ability to preserve the 
variance of the data compared to other popular, if simpler, high variance methods.  
Aside from the obvious numerical relevance of missing value estimation, another key 
driver is the biological significance of imputation, particularly algorithmic performance 
in estimating significant genes in microarray data that may be erroneously affected. 
Plakophilin 2 (PKP2) for example, is present in breast carcinoma cell lines25 and is 
significant as it serves as a marker for the identification and characterisation of 
carcinomas derived either from or corresponding to, simple and complex epithelia26. As 
will be witnessed in Section 6, PKP2 is often not selected by gene selection methods 
when missing values are present and so would generally be either ignored or replaced 
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when conventional estimation methods are applied. By judiciously employing a flexible 
imputation strategy such as HCMVI however, the probability that these genes are 
correctly selected can be significantly enhanced. Similarly, the GRN reconstruction 
performance may be significantly influenced by missing values with a substantial 
number of vital co-regulation links being neglected when imputing by traditional and 
contemporary methods (Sections 3 and 4). The interaction in breast cancer data between 
ADP-ribosylation factor 3 and ESTs (Estrogen Sulfotransferase), which is similar to the 
NSAP1 protein is, for instance, consistently overlooked when missing values are 
introduced, though they have been successfully reconstructed using flexible imputation 
methods (Section 5). In both scenarios, accurate imputation crucially eliminates the 
need for repeating an experiment which can be costly, and may be pragmatically 
infeasible.  
This paper presents a treatise on existing imputation methods by examining their 
performance in managing microarray dataset missing values to improve post genomic 
knowledge discovery. Concomitant with analysing the numerical accuracy of 
imputation, the biological significance for two proteins is analysed, namely KIAA1025 
and MHCα from the breast and ovarian cancer datasets respectively, because of their 
acknowledged importance in diagnosing the different cancer types27-29.  
The remainder of the paper is organized as follows: after formally defining the 
nomenclature, Sections 3, 4 and 5 will respectively review the gamut of traditional, 
contemporary and flexible microarray missing value imputation algorithms together 
with their particular epithets and limitations. A reflective analysis is then presented in 
Section 6 upon a series of experiments performed on various breast and ovarian cancer 
microarray datasets, including both statistical and biological significance interpretations, 
6 
while some conclusions are provided in Section 7. 
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Figure 1: A Schematic Representation of Post Genomic Knowledge Discovery 
Framework 
2. Nomenclature 
The convention adopted in all the imputation strategies is to assume the gene expression 
matrix Y has m rows and n columns, where the rows and columns represent genes and 
samples respectively as in (1). A missing value in gene expression data Y for gene i and 
sample j is formally expressed as Yij.  
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Imputation strategies have been broadly classified into three categories: traditional, 
contemporary and flexible techniques. Original imputation approaches, which replace a 
missing value by either zero or row/column mean, are designated as traditional, as they 
are simple and computationally efficient, but do not take advantage of any latent 
correlation within the data. Contemporary techniques subsequently evolved to improve 
the estimation accuracy by using inherent data correlations, usually under the 
assumption that the causal correlation structure is either localised or global. They are 
also characterised by using a fixed number of predictor genes in the estimation which 
limits the flexibility to fully exploit any data correlations. This was the incentive for the 
most recent family of flexible imputation methods which are able to freely adapt to the 
data distribution by automatically determining the optimal number of predictor genes, 
thereby minimising the impact of missing values on subsequent biological analysis. In 
the following sections, these three imputation categories are respectively reviewed. 
3. Traditional Imputation Techniques for Microarray Data 
These are broadly characterised by replacing expression values of those genes that 
posses missing values by zero, their gene/sample mean or median and in certain cases, 
by using the well-known KNN method. The advantages and disadvantages of these 
popular approaches are now discussed. 
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ZeroImpute and Mean/Median Imputation 
In these methods, missing values are respectively replaced by either zero (ZeroImpute) 
or the gene/sample average30 and/or median. The attraction is their simplicity and 
computational efficiency, though none take advantage of the underlying correlation 
structure of the data, with the consequence that the data variance is generally high. This 
means when there are a large number of missing values present in the microarray data 
these imputation strategies can significantly compromise subsequent post genomic 
analysis. The impact however, can be reduced by adapting the estimation parameters to 
the underlying correlation structure of the data, with the following sections examining 
some well-established methods. 
Singular Value Decomposition Based Imputation (SVDImpute)  
This uses the combination of Singular Value Decomposition (SVD) 9 and Expectation 
Maximization (EM)31 to estimate the missing values by calculating mutually orthogonal 
expression patterns often referred to as Eigen genes. As SVD calculations require the 
entire matrix, missing values are replaced by their row mean prior to the k most 
effective Eigen genes being selected according to their corresponding Eigen values. The 
imputed missing value estimate for Yij is then calculated by regressing gi against the k 
most effective Eigen genes with expression values from sample j which contained the 
missing value being ignored. SVDImpute reduces imputation errors by recursively 
estimating the missing values using the EM algorithm until the change in the matrices 
becomes less than an empirically determined threshold, nominally 0.01 9. The technique 
performs best when 20% of the Eigen genes are used for estimation, and while it is a 
better strategy than high-variance approaches like ZeroImpute, it has the drawbacks of 
both being highly sensitive to noise and only considering global data correlations, which 
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inevitably leads to higher estimation errors in locally correlated datasets.  
K-Nearest Neighbour (KNN) Estimation  
KNN9 estimates missing values by searching for the k nearest genes normally by 
applying the Euclidean distance and then taking the weighted average of these k genes. 
The k genes whose expression vectors are most similar to genetic expression values in 
all samples, except the sample which contains the missing value, are selected. The 
similarity measure between gene gi and other genes is then determined by the Euclidian 
distance over the observed components in sample j, and the missing value estimated as 
the weighted average of the corresponding entries in the selected k expression vectors, 
where the contribution of every gene is scaled by the similarity of its expression to gi.  
While KNN is flexible in terms of the choice of similarity measure, it does imply the 
performance of a specific metric is data dependent. Troyanskaya et al 9 demonstrated 
that Euclidean distance performs better than other similarity measures for microarray 
data, and though it is highly sensitive to microarray data outliers,  log-transforming the 
data can significantly reduce their effect in determining gene similarity.  
The choice of an appropriate k value especially influences imputation performance. 
Experimental results have established that for small datasets k=10 is the best choice7, 
while Toyanasaka et al9 observed that KNN is insensitive to values of k in the range 10 
to 20. The key point to emphasise is that regardless of the underlying structure of the 
microarray data, a preset value of k is employed which clearly does not fully harness the 
capability of an imputation method. A much more creative strategy is to endeavour to 
automatically determine the best k value from the data correlation structure, which is the 
fundamental premise of the two flexible imputation techniques described in Section 5.  
Summarising, while traditional algorithms have been widely adopted, the inherently 
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high data variance has a major impact on downstream analysis methods like significant 
gene selection and class prediction GRN reconstruction. To relax this restriction, more 
robust techniques have evolved in an attempt to garner superior performance in terms of 
estimation accuracy, although as will be witnessed, they still exhibit some limitations, 
most notably from a biological significance perspective. The next section focuses on 
some of the most well-established contemporary imputation approaches.  
4. Contemporary Imputation Techniques for Microarray Data 
This category embraces those methods that implicitly attempt to lower the data variance 
of missing value estimates, by seeking to exploit the underlying localised or global 
correlation structure of the microarray data. Some of the most popular algorithms 
together with their relative merits and demerits will now be investigated.   
Least Square Impute Estimation (LSImpute)  
This is a regression-based method that exploits the correlation between genes. There are 
three variants of the imputation LSImpute10 algorithm, namely: LSImpute-Gene, 
LSImpute-Array and LSImpute-Adaptive. LSImpute-Gene estimates missing values 
using the correlation between the genes (intra-sample) while LSImpute-Array exploits 
inter-sample correlation while LSImpute-Adaptive combines both techniques using a 
bootstrapping approach32. The communal features of all three LSImpute variants will 
now be delineated.  
To estimate missing value Yij in (1), the k-most correlated genes are firstly selected, 
whose expression vectors are similar to gene i from Y in all samples except j, where all 
the correlated genes do not contain any missing values. As LSImpute-Gene is based 
upon a regression, it mandates the number of model parameters must be lower than the 
number of observations, though in general for microarray data, the number of genes is 
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usually much greater than the sample number. The algorithm then computes regressive 
estimates for each selected gene and the missing value estimate is obtained from their 
weighted average. 
While LSImpute-Gene affords greater accuracy than traditional imputation methods 
like KNN and SVDImpute (Section 3), it still has the same fundamental limitation of 
using a preset k value. Bø et al 10 for example, empirically determined k =10 as the most 
suitable value for their particular dataset, though crucially this finding is data dependent 
and not generic. It also demonstrated this imputation approach works better if missing 
values have been initially approximated by LSImpute-Gene and then refined with 
LSImpute-Array. This lowers the imputation error, though commensurately it increases 
the computational overhead, and since it still employs LSImpute-Gene prior to any 
estimation, the value of k is always fixed. 
LSImpute-Adaptive combines the strengths of both LSImpute-Gene and LSImpute-
Array by fusing their respective imputation results. It modifies the weights for each 
imputation using a bootstrapping process32, with empirical results10 endorsing that this 
strategy performs better than when either variant is separately applied. 
With the flexibility to adjust the number of predictor genes in the regression, 
LSImpute performs best when data exhibits a strong local correlation structure, though 
the comparative prediction accuracy is still inferior to that achieved by the new flexible 
imputation algorithms, which dynamically determine k directly from the data (Section 
5). 
Bayesian Principal Component Analysis (BPCA) Estimation12 
BPCA estimates missing values using Bayesian estimation theory with a variational 
algorithm33 to calculate the model parameters and ultimately the imputed value Yij. The 
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posteriori distribution p(Yij) of the missing value and the posteriori distribution p(θ) of 
the model parameter θ is firstly computed from gene values having no missing values 
and since this distribution calculation requires the complete matrix, so missing values 
are replaced by their corresponding gene averages.  The model parameters p(θ) are then 
used to compute the current posteriori distribution, with the maximum likelihood32 
parameters being iteratively updated using the current posteriori distribution of model 
parameters and missing values, until convergence is reached.  
By considering only global correlations within a dataset, BPCA has a distinct 
advantage in terms of prediction speed compared with all the other imputation 
techniques analysed, but its performance is highly dependent on either a strong 
underlying global correlation within the data or having a very high number of samples. 
This is offset by the likelihood of high imputation errors when either the dataset is 
locally correlated or comprises a small number of samples.  
Collateral Missing Value Estimation (CMVE)11 
This algorithm is unique in contemporary missing value imputation techniques in using 
multiple estimates. Like LSImpute, it firstly estimates the missing value Yij by 
identifying the k most correlated genes, with either a covariance or Pearson correlation 
matrix being employed, depending upon the data distribution, to find these correlated 
genes. LS regression and two variants of the Non Negative LS (NNLS) algorithm are 
then applied to compute three separate estimates for Yij, which are then linearly fused as 
follows: 
1 2 3. . .ijY ρ= Φ + ΔΦ +ΛΦ  (2) 
where ρ, Δ and Λ are the weights assigned to each constituent imputation estimate.  
CMVE uses LS regression of k correlated genes for the first missing value estimate 
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Φ1, while NNLS and linear programming compute the other two estimates Φ2 and Φ3.  
The rationale for including NNLS is that unnormalised microarray data has only 
positive values so NNLS takes advantage of exploiting the positive search space. If the 
data is either normalized or log-transformed then, it will contain some negative values 
so LS regression is used for this particular estimation. Since both the Pearson 
correlation and covariance functions necessitate complete imputation matrices, so, 
CMVE firstly replaces all missing values by gene averages. Once the initial missing 
value estimate is generated, then new estimated value is used in all future predictions, 
which is a distinctive feature of this particular imputation strategy.  
CMVE has been proven to perform best for locally correlated data, providing 
consistently superior imputation quality compared to all the aforementioned techniques, 
by virtue of the property of recycling estimated values in future predictions34. It is also 
more robust as witnessed by its performance in the presence of high numbers of missing 
values. The main drawback of CMVE, just like all the other contemporary algorithms, is 
the preset value of k which means it does not fully adapt to the correlation structure of 
the data and compromises performance when data has a global structure. 
In summarising the imputation methods reviewed so far, the main assumption relates 
to the underlying correlation structure of the dataset, where KNN, LSImpute and CMVE 
perform better when data is locally correlated, while SVDImpute and BPCA are more 
apposite for missing value estimation in globally correlated datasets. From a post 
genomic knowledge inference viewpoint however, any estimation strategy must be to 
adapt to the correlation data structure so imputation performs equally well for both 
types of correlated data. The next section presents two recent flexible imputation 
methods that exhibit this propitious property, in automatically adapting to the data 
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correlation structure to produce minimal imputation error. 
5. Flexible Imputation Techniques for Microarray Data 
Flexible imputation techniques use to some extent, core building blocks developed for 
their contemporary estimation counterparts in Section 4, and are characterised by 
automatically selecting a priori, the optimal number of estimator genes from the data 
correlation structure. This avoids the problem that if the data is globally correlated, then 
a small number of predictor genes (low k value) may ignore genes that are strongly 
correlated to the gene having the missing value. Conversely when an unnecessarily 
large value of number of genes (high k value) is used this can introduce genes for 
prediction which either has little or no correlation to the gene with missing values. Two 
techniques are reviewed in this category. 
 
Local Least Square Impute (LLSImpute) 8 
This is similar to LSImpute in that it estimates missing values by constructing a linear 
combination of correlated genes using LS principles. The crucial difference is that in 
estimating Yij,, the number of predictor genes k is heuristically determined directly from 
the dataset. To determine the optimum k, LLSImpute artificially removes a known value 
from the most correlated gene gi before iteratively estimating it over a range of k values, 
with the k that produces the minimum estimation error then being used for imputation.  
Kim et al 8 employed the L2 norm as well as Pearson correlation to identify the most 
correlated genes, with the L2 norm reported to perform slightly better than the Pearson 
correlation method for the chosen experimental data, although the difference in 
prediction accuracies between the two approaches was statistically insignificant.  
In comparison with the various traditional and contemporary approaches, LLSImpute 
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adapts to the underlying correlated data structure, with the corollary being superior 
imputation performance, and while it incurs a considerably higher computational cost, 
from a microarray data perspective, missing value estimation accuracy always has a 
greater priority than computational complexity.  
 
Heuristic Collateral Missing Value Imputation (HCMVI)13  
This uses the multi-estimate CMVE algorithm11 detailed in Section 4, as its kernel 
building block to formulate the final imputation of missing value Yij. It is analogous to 
LLSImpute in that it also automatically determines the optimal number of predictor 
genes k by using Monte Carlo (MC) simulation35. It selects multiple matrices with 
known gene expression values with each matrix36 having a selection probability=0.05 in 
the MC simulation. HCMVI then identifies the most correlated matrix from the Pearson 
correlation37 between each selected matrix and the gene expression Y. These known 
values are then estimated by CMVE for a range of k values, with the optimal k being the 
one that generates the minimum estimation error.   
HCMVI retains all the enhanced imputation performance characteristics and 
advantages of the original CMVE algorithm, while crucially automatically adapting to 
the underlying correlation structure of the microarray data, though as with LLSImpute, it 
incurs an additional computational overhead.  
6. Discussion of Results 
This section will rigorously examine the influence of the aforementioned imputation 
strategies have in improving missing-value estimation accuracy for post-genomic 
knowledge discovery methods such as significant gene selection38, allied with the 
biological significance of the imputation. Six different microarray datasets for breast 
16 
and ovarian cancer tissues are used, with data being log-transformed and normalized, so 
that 0=x and 12 =σ , in order to remove all experimental variations. 
The breast cancer dataset17 contained 7, 7, 8 samples of BRCA1, BRCA2 and 
Sporadic mutations (neither BRCA1 nor BRCA2) respectively, while the ovarian cancer 
dataset 18 contained 16, 16 and 18 samples respectively of BRCA1, BRCA2, Sporadic 
mutations. Each breast cancer data sample contained microarray data of 3226 genes and 
there were 6445 genetic expressions per sample for the ovarian dataset. It is worth 
noting that number probes in both breast and ovarian cancer datasets are different. The 
data are generated by different labs under different experimental conditions and thus 
represent experimental variations. 
To equitably evaluate the performance of the traditional and contemporary imputation 
algorithms on downstream biological analysis methods, the number of predictor genes 
was fixed at k=10 in all experiments. In contrast, the two flexible imputation methods 
(LLSImpute and HMCVI) automatically determine k by adapting to the correlation 
structure of the data. Also in this empirical analysis, the LLSImpute variant based upon 
the L2 norm is applied due to its superior performance8. In the next section, the 
influence of imputation on both significant gene selection and GRN reconstruction 
(STEP 4 in Figure 1) is investigated. 
 
Imputation and Biological significance of selected genes 
To explore the impact of each estimation algorithm upon significant gene selection, a 
set of genes (Gorg) has been chosen from the original dataset using the Between Sum of 
Squares to Within Sum of Squares (BSS/WSS)35 method which identifies genes that 
concomitantly have large inter-class and small intra-class variations. The main reason 
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for adopting this particular method is its proven superior performance capability to 
select significant genes compared with other popular methods such as the t-test39. To 
assess the effect of missing values on gene selection, experiments were performed 
across a missing value range of probabilities from 0.01 to 0.2, with values being 
iteratively removed from the original gene expression in (1). These were then estimated 
using ZeroImpute, KNN, LLSImpute, BPCA, CMVE and HCMVI respectively to form 
Yest prior to being applied to selected sets of p genes using BSS/WSS, for each 
respective estimation matrix. The selected genes have been then compared with Gorg to 
obtain the true positive percentage accuracy (%Accuracy) metric, to provide a 
dispassionate measure of the estimation performance of each algorithm. 
To eliminate performance variations with respect to the number of selected genes in 
the BSS/WSS method, each imputation technique was tested for 50 and 1000 significant 
genes, with the results in Figures 2–5 displaying the respective gene selection 
performance for both the breast and ovarian cancer datasets. These clearly reveal that 
the flexible imputation methods (LLSImpute and HCMVI) consistently produce superior 
performance for both cancer datasets, with HCMVI provides the highest %Accuracy 
metric in the experiments. In contrast, contemporary imputation algorithms like CMVE 
and BPCA were unable to maintain their performance across both datasets, though 
interestingly, CMVE performed better than LLSImpute as well as all the other 
contemporary imputation methods for the breast cancer dataset, which has a 
predominantly localised data correlation structure. This was not however, maintained 
for the more globally correlated ovarian cancer dataset, where BPCA performed better, 
though it correspondingly failed to sustain the improved estimation accuracy for the 
breast cancer data. Not surprisingly, the high-variance traditional imputation approaches 
18 
such as ZeroImpute and KNN exhibit the poorest performance in Figures 2–5, for both 
cancer datasets, confirming the judgement that incorrectly imputed missing values can 
have a significant potential impact upon overall gene selection performance.  
 
Gene Selection Accuracy for 50 Significant Genes in Breast Cancer
0
20
40
60
80
100
0 5 10 15 20
% Missing Values
%
 A
cc
ur
ac
y
HCMVI
CMVE
BPCA
LLSImpute
KNN
ZeroImpute
 
Figure 2: Gene Selection Accuracy for 50 Significant Genes in Breast Cancer  
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Gene Selection Accuracy for 1000 Significant Genes in Breast Cancer
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Figure 3: Gene Selection Accuracy for 1000 Significant Genes in Breast Cancer 
Gene Selection Accuracy for 50 Significant Genes in Ovarian Cancer
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Figure 4: Gene Selection Accuracy for 50 Significant Genes in Ovarian Cancer 
 
20 
Gene Selection Accuracy for 1000 Significant Genes in Ovarian Cancer
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Figure 5: Gene Selection Accuracy for 1000 Significant Genes in Ovarian Cancer 
 
 
Imputation algorithm performance has normally only been assessed numerically, with 
considerable debate within the research community of the suitability of standard 
evaluation measures, such as Normalised RMS Error (NRMSE). Interpreting the results 
from a biological significance perspective has not received the same attention, though 
the impact of missing values on selected genes in post genomic knowledge discovery is 
clearly a major factor in algorithmic performance assessment. 
 
Biological Significance of Imputation 
While the primary focus is on the estimation accuracy of an imputation method, it is 
equally important to conduct an investigation into the biological significance of certain 
selected genes for the respective datasets when evaluating the impact of missing values 
on gene selection. Indeed, it is constructive to ascertain whether a particular imputation 
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technique assists the gene selection methods in identifying known and novel genes for a 
given sample. This may provide not only valuable information for the design of basic 
mechanistic, diagnostic and biomarker studies, but also valuable data for use in the 
construction of gene networks and pathways involved in processes like oncogenesis and 
resistance to tumour induction.  
In examining the results for both the breast and ovarian cancer datasets, a number of 
genes were overlooked using traditional methods, when missing values were introduced 
and processed, which independent experiments40 have confirmed alter expressions in 
tumor lines and so can be very important in oncogenesis. This set of genes have not 
only been selected by the BSS/WSS algorithm, but have been revalidated using the 
modified t-test with greedy pairs method41 which minimizes the bias of the gene 
selection strategy towards either a particular imputation technique or a set of genes. 
As the results for various gene selection algorithms in Table 1 reveal, that the 
KIAA1025 protein was not always correctly selected when missing values were 
imputed using KNN, BPCA CMVE and LLSImpute, but were consistently identified by 
HCMVI. This is a vital protein which is co-regulated with estrogen receptors for both in 
vivo and clinical data, which are expressed in more than 66% of human breast tumors29. 
Another gene always selected by HCMVI across the range of missing values is 
plakophilin 2 (PKP2) which is a common protein and exhibits a dual role, appearing as 
both a constitutive karyoplasmic protein and a desmosomal plaque component for all 
the desmosome-possessing tissues and cell culture lines. The gene is found in breast 
carcinoma cell lines25 and furthermore, because of its significance, it can serve as a 
marker for the identification and characterisation of carcinomas derived either from or 
corresponding to, simple or complex epithelia 26. 
22 
Similar observations can be drawn from the study of significant genes in the ovarian 
cancer dataset in Table 2. For instance, MHC Class II=DQ alpha (MHCα) and MHC 
Class II=DQ beta (MHCβ) genes are linked to the immune system and have been shown 
to be down-regulated for ovary syndrome27. The allele gene is also present at a higher 
frequency in patients with malignant melanoma than in Caucasian controls. These genes 
help in particular to diagnose melanoma patients in the relatively advanced stages of the 
disease and/or patients who are more likely to have a recurrence28. The results confirm 
that these genes have been correctly identified by the flexible HCMVI method, while 
being consistently overlooked by other techniques, most notably by all traditional 
imputation algorithms, for missing values probabilities greater than 0.05. 
Interestingly for both cancer datasets, across the full missing value range from 1% to 
20%, these regulated genes have been correctly identified when gene selection has been 
preceded by HCMVI imputation as confirmed in Tables 1 and 2. It highlights that 
consideration of the biological significance of any imputation is extremely important 
and underscores the need for accurate estimation prior to gene selection, particularly in 
the presence of higher numbers of missing values. 
Table 1. KIAA1025 and Plakophilin2 Selection in breast cancer dataset across the range of 
missing values 
% MV HCMVI CMVE LLSImpute BPCA KNN ZeroImpute 
1 KIAA1025  
Plakophilin2 
KIAA1025  
Plakophilin2 
KIAA1025   KIAA1025 
5 KIAA1025  
Plakophilin2 
KIAA1025  
Plakophilin2 
KIAA1025    KIAA1025 
10 KIAA 
Plakophilin2 
KIAA 
Plakophilin2 
    
15 KIAA1025  
Plakophilin2 
KIAA1025  
Plakophilin2 
 
 
   
20 KIAA1025  
Plakophilin2 
     
 
 
Table 2. MHC Class II=DQ alpha (MHCα) and MHC Class II=DQ beta (MHCβ) selection in ovarian 
cancer across the range of missing values 
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% MV HCMVI CMVE LLSImpute BPCA KNN ZeroImpute 
1 MHCα 
MHCβ 
MHCα MHCα MHCα MHCα MHCα 
5 MHCα 
MHCβ 
MHCβ     
10 MHCα 
MHCβ 
     
15 MHCα 
MHCβ 
     
20 MHCα 
MHCβ 
     
 
As alluded earlier, existing GRN reconstruction methods conventionally replace missing 
values by either ZeroImpute or gene average30,42, despite both inevitably impacting upon 
subsequent GRN reconstruction, as will now be more fully examined. 
 
Impact of Missing Values on Gene Regulatory Network Reconstruction  
To evaluate the influence of missing values, the Algorithm for the Reconstruction of 
Accurate Cellular Networks (ARACNe) 43 has been employed because it affords better 
performance over alternative approaches like Bayesian Networks44 and has been tested 
for mammalian gene network reconstruction and compared with other techniques that 
are normally applied to simple eukaryotes such as for instance, Saccharomyces 
Cerevisiae 45.  
ARACNe firstly computes the statistical significant gene-gene co-regulation using 
mutual information before applying a data processing inequality to prune indirect 
relationships, i.e. genes which are co-regulated by either one or more intermediate 
genes. To comparatively evaluate the respective imputation performances on GRN 
reconstruction, the number of conserved links is determined, which represents whether a 
particular co-regulation link is present in both GRNorg and GRNimputed. The gene network 
GRNorg is then initially constructed using ARACNe from the original data Y with no 
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missing values. As in the previous experiments, up to 20% missing values have been 
randomly introduced and then respectively estimated using traditional, contemporary 
and flexible imputation methods (Section 3–5 respectively).. The corresponding gene 
networks GRNimputed are then constructed from the imputed data and GRNorg and 
GRNimputed compared to ascertain the Conserved Links. 
  Figures 6-9 show that the ARACNe method, which has been reported to be robust46 for 
GRN construction, does not maintain its performance in the presence of missing values, 
especially for ZeroImpute. In contrast, when a flexible imputation method like HCMVI 
is applied, ARACNe conserves the number of links even at higher missing value 
probabilities. For example, in BRCA1 breast cancer data, the transcriptional link 
between ADP-ribosylation factor 3 (ARF3) and general transcription factor II, i, 
pseudogene 1(GTF2IP1) was overlooked when missing values were imputed by all 
traditional and contemporary methods, but was correctly inferred when values were 
imputed by both HCMVI and LLSImpute. Similarly, the link between HS1 binding 
protein and mitogen-activated protein kinase 3 in BRCA2 breast cancer data was 
reconstructed when values were imputed using HCMVI, but was neglected by all other 
techniques. The results for breast cancer Sporadic data revealed similar observations, 
with for example, the interaction between ADP-ribosylation factor 3 and  EST, which is 
very similar to the NSAP1 protein, being identified when data was imputed using 
flexible methods, while being missed by the other strategies, so corroborating the 
importance of accurate imputation in improving GRN reconstruction performance. 
In the ovarian cancer dataset, the interaction link between Ro ribonucleoprotein 
autoantigen (Ro/SS-A)=autoantigen calreticulin and Glutathione S-transferase theta 1 
was not identified in BRCA1-data, when missing values were introduced but was 
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regenerated when these missing values were imputed using HCMVI. Similarly, co-
regulation between Inhibitor of DNA binding 3, dominant negative helix-loop-helix 
protein and p53 in BRCA2 ovarian cancer dataset was also missed, but the link was 
reconstructed when HMCVI imputation was applied across the range of missing values. 
In the Sporadic ovarian cancer dataset, transcriptional links between CD97 and RAB-10 
were again only successfully reconstructed using HCMVI, while they were overlooked 
by all other estimation methods again underpinning the significance of accurate missing 
value imputation prior to GRN reconstruction. 
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Figure 6: Accuracy of Conserved Links in BRCA1-Breast Cancer Data 
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Figure 7: Accuracy of Conserved Links in Sporadic-Breast Cancer Data 
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Figure 8: Accuracy of Conserved Links in BRCA1-Ovarian Cancer Data 
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Figure 9: Accuracy of Conserved Links in BRCA2-Ovarian Cancer Data 
The impact of missing values on GRN was further investigated on artificially created 
networks. Two artificial expression data sets and networks by Bansal et al47 was used 
for this purpose. Each expression data had 100 probes with 100 samples per probe. The 
networks were constructed using ARACNE with no imputation and compared against 
artificial networks to compute reference area under Receiver Operating Characteristic 
(ROC) curve. Then, 20% missing values were introduced and imputed using HCMVI 
which was followed by network reconstruction using ARACNE under same 
experimental setup to compute area under ROC curve. Figure 10 shows average ROC 
curve for 10 runs with and without imputation. The areas under ROC curve for 
networks 1 and 2 were 0.6653 and 0.5979 respectively when networks were constructed 
from complete dataset. The average areas under ROC were 0.6653 and 0.5901 
respectively when networks were constructed after randomly introducing 20% missing 
values and estimation using HCMVI. Again, the result show that network inference 
performance is upheld if accurate imputation is used prior constructing networks. 
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Figure 10: ROC Plots of Artificial Networks 
  
Significance Test Results 
For completeness, the statistical significance and variance stability of all the various 
imputation methods has been analysed using the two-sided Wilcoxon Rank sum 
statistical significance test. The impetus for applying this test is that it doesn’t assumes 
that data is coming from same distribution, which is particularly important given the 
data variance can be appreciably disturbed by erroneous estimation, as for instance in 
ZeroImpute. To test the hypothesis H0, Y = Yest where Y and Yest are the actual and 
estimated matrices respectively, the P-Value of the hypothesis is determined: 
1 )0, r rH  P-Value 2P (R y= − ≤  (3) 
where yr is the sum of the ranks of observations for Y and R is the corresponding random 
variable. The corresponding results shown in box plot in Figures 11–16 demonstrate 
that traditional approaches tend to rapidly degrade at higher numbers of missing values, 
while both contemporary and flexible imputation techniques maintain a far more 
consistent performance across the range of missing values, see notably in Figures 12 
and 14.  As box plot can be used to display smallest observation, lower quartile, median, 
upper quartile and largest observation and it can also show, if any value is an outlier. 
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This corroborates the fundamental hypothesis that a suitably accurate imputation 
strategy should always be employed for microarray data before any biological down-
streaming analysis is undertaken.  
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Figure 11: Significance Test Results for BRCA1-Breast Cancer Data 
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Figure 12: Significance Test Results for BRCA2-Breast Cancer Data 
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Figure 13: Significance Test Results for Sporadic-Breast Cancer Data 
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Figure 14: Significance Test Results for BRCA1-Ovarian Cancer Data 
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Figure 15: Significance Test Results for BRCA2-Ovarian Cancer Data 
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Figure 16: Significance Test Results for Sporadic-Ovarian Cancer Data 
Normalized Root Mean Square Error 
For completeness the estimation performance of HCMVI and comparative imputation 
methods was also analyzed using the traditional parametric Normalized Root Mean 
Square (NRMS) Error measure, despite its limitations in reflecting the true impact of 
missing values on subsequent biological analysis. NRMS Error is defined as: 
( )
( )
estRMS Y Y
RMS Y
−Θ =
 
(2)
where Y is the original data matrix and Yest is the estimated matrix using HCMVI, 
CMVE, BPCA, LLSImpute and KNN respectively. This particular measure has been 
used by Sehgal et al, 11, Ouyang et al, 48 and Tuikkala et al 49 for error estimation 
because Θ =1 for zero imputation.  
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Figure 17: NRMS Error in BRCA1-Breast Cancer Data 
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Figure 18- NRMS Error in BRCA2-Breast Cancer Data 
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Figure 19: NRMS ERROR in Sporadic-Breast Cancer Data 
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Figure 20: NRMS ERROR in BRCA1-Ovarian Cancer Data 
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Figure 21: NRMS ERROR in BRCA2-Ovarian Cancer Data 
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Figure 22: NRMS ERROR in Sporadic-Ovarian Cancer Data 
Figures 17-22 show boxplot of NMRS Error for different imputation algorithms (See 
supplementary material for the rest of the results). It again confirms the better 
performance of HCMVI (See notably Figure 19) and reiterates the value of accurately 
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exploiting information about the underlying correlation structure of the data instead of 
using a preset value. Interestingly LLSImpute exhibited similar performance to HCMVI 
so justifying the merit of using other metrics to dispassionately compare the 
performance of different imputation strategies. 
7. Conclusion 
This paper has pragmatically argued that imputation can be effectively applied to 
recycle microarray data and in doing so, provide many potential benefits ranging from 
cost savings to performance enhancements in post genomic knowledge discovery. 
While cognisance is made that ZeroImpute and other traditional missing value 
imputation strategies are straightforward to implement, new flexible methods have been 
proven to exhibit much superior accuracy and performance from both a statistical and 
biological significance perspective, by virtue of their innate ability to exploit any 
underlying data correlation structures. A comprehensive study of missing values in 
microarray data has been presented and their subsequent impact upon post genomic 
knowledge discovery methods, including significant gene selection and gene regulatory 
network reconstruction has been investigated. Empirical analysis has consistently shown 
that rather than merely ignoring missing values, which has been the preferred approach 
to resolve this problem, flexible and robust imputation algorithms afford considerable 
performance benefits and so should wherever possible, be mandated prior to any 
knowledge inference process using microarray data.  
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